Prenatal exposure to polycyclic aromatic hydrocarbons, benzo[a]pyrene-DNA adducts, and genomic DNA methylation in cord blood

Environmental Health Perspectives

Volumn 120, Issue 5, 2012, Pages 733-738

  Herbstman, Julie B ^a   Tang, Deliang ^a   Zhu, Deguang ^a   Qu, Lirong ^a   Sjödin, Andreas ^b   Li, Zheng ^b   Camann, David ^c   Perera, Frederica P ^a  

^a Mailman School of Public Health ^*  (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SOUTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Adducts; Epigenetics; Methylation; Polycyclic aromatic hydrocarbons; Prenatal; Umbilical cord blood

Indexed keywords

BENZO[A]PYRENE;

ADULT; AIR MONITOR; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA ADDUCT; DNA METHYLATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE; LONGITUDINAL STUDY; NORMAL HUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; UMBILICAL CORD BLOOD;

EID: 84861049327     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104056     Document Type: Article

References (37)

1. Alexandrov K, Rojas M, Geneste O, Castegnaro M, Camus AM, Petruzzelli S, et al. 1992. An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 52(22):6248-6253.
2. Baron RM, Kenny DA. 1986. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51(6):1173-1182.
3. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. 2009. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 169(2):236-248.
4. Chen JX, Zheng Y, West M, Tang MS. 1998. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res 58(10):2070-2075.
5. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. 1997. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci USA 94(8):3893-3898.
6. Denissenko MF, Pao A, Tang M, Pfeifer GP. 1996. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274(5286):430-432.
7. Dolinoy DC, Weidman JR, Jirtle RL. 2007. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23(3):297-307.
8. Drahovsky D, Morris NR. 1972. Mammalian DNA methylase: binding and methylation site selection. Hoppe Seylers Z Physiol Chem 353(5):700-701.
9. Fang X, Dong W, Thornton C, Willett KL. 2010. Benzo[a]pyrene effects on glycine N-methyltransferase mRNA expression and enzyme activity in Fundulus heteroclitus embryos. Aquat Toxicol 98(2):130-138.
10. Hoffmann MJ, Schulz WA. 2005. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83(3):296-321.
11. Kriek E, Rojas M, Alexandrov K, Bartsch H. 1998. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res 400(1-2):215-231.
12. Li Z, Romanoff LC, Trinidad DA, Hussain N, Jones RS, Porter EN, et al. 2006. Measurement of urinary monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas chromatography/isotope dilution high-resolution mass spectrometry. Anal Chem 78(16):5744-5751.
13. Miller RL, Garfinkel R, Lendor C, Hoepner L, Li Z, Romanoff L, et al. 2010. Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr Allergy Immunol 21(2 pt 1):260-267.
14. Pavanello S, Bollati V, Pesatori AC, Kapka L, Bolognesi C, Bertazzi PA, et al. 2009. Global and gene-specific promoter methylation changes are related to anti-B[a]PDE-DNA adduct levels and influence micronuclei levels in polycyclic aromatic hydrocarbon-exposed individuals. Int J Cancer 125(7):1692-1697.
15. Perera FP, Illman SM, Kinney PL, Whyatt RM, Kelvin EA, Shepard P, et al. 2002. The challenge of preventing environmentallyrelated disease in young children: community-based research in New York City. Environ Health Perspect 110:197-204.
16. Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, et al. 2003. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 111:201-205.
17. Perera FP, Rauh V, Whyatt RM, Tsai WY, Tang D, Diaz D, et al. 2006. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect 114:1287-1292.
18. Perera FP, Tang D, Tu YH, Cruz LA, Borjas M, Bernert T, et al. 2004. Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect 112:1133-1136.
19. Perera F, Tang D, Whyatt R, Lederman SA, Jedrychowski W. 2005. DNA damage from polycyclic aromatic hydrocarbons measured by benzo[a]pyrene-DNA adducts in mothers and newborns from northern Manhattan, the World Trade Center Area, Poland, and China. Cancer Epidemiol Biomarkers Prev 14(3):709-714.
20. Pfeifer GP. 2006. Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol 301:259-281.
21. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. 2002. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21(48):7435-7451.
22. Pirogov N, Shafirovich V, Kolbanovskiy A, Solntsev K, Courtney SA, Amin S, et al. 1998. Role of hydrophobic effects in the reaction of a polynuclear aromatic diol epoxide with oligodeoxynucleotides in aqueous solutions. Chem Res Toxicol 11(4):381-388.
23. Sadikovic B, Andrews J, Rodenhiser DI. 2007. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells. Toxicol Appl Pharmacol 225(3):300-309.
24. Sadikovic B, Rodenhiser DI. 2006. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol Appl Pharmacol 216(3):458-468.
25. Sowers LC, Shaw BR, Sedwick WD. 1987. Base stacking and molecular polarizability: effect of a methyl group in the 5-position of pyrimidines. Biochem Biophys Res Commun 148(2):790-794.
26. Subach OM, Baskunov VB, Darii MV, Maltseva DV, Alexandrov DA, Kirsanova OV, et al. 2006. Impact of benzo[a]pyrene-2'-deoxyguanosine lesions on methylation of DNA by SssI and HhaI DNA methyltransferases. Biochemistry 45(19):6142-6159.
27. Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, et al. 2008. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 17(9):2306-2310.
28. Tonne CC, Whyatt RM, Camann DE, Perera FP, Kinney PL. 2004. Predictors of personal polycyclic aromatic hydrocarbon exposures among pregnant minority women in New York City. Environ Health Perspect 112:754-759.
29. Tretyakova N, Guza R, Matter B. 2008. Endogenous cytosine methylation and the formation of carcinogen carcinogen-DNA adducts. Nucleic Acids Symp Ser (Oxf) (52):49-50.
30. Tretyakova N, Matter B, Jones R, Shallop A. 2002. Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras and p53 gene sequences: stable isotope-labeling mass spectrometry approach. Biochemistry 41(30):9535-9544.
31. Veglia F, Loft S, Matullo G, Peluso M, Munnia A, Perera F, et al. 2008. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis. Carcinogenesis 29(5):932-936.
32. Weisenberger DJ, Romano LJ. 1999. Cytosine methylation in a CpG sequence leads to enhanced reactivity with benzo[a]pyrene diol epoxide that correlates with a conformational change. J Biol Chem 274(34):23948-23955.
33. Whyatt RM, Bell DA, Jedrychowski W, Santella RM, Garte SJ, Cosma G, et al. 1998. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19(8):1389-1392.
34. Wickham H. 2009. ggplot2: Elegant Graphics for Data Analysis. New York:Springer.
35. Wilson AS, Power BE, Molloy PL. 2007. DNA hypomethylation and human diseases. Biochim Biophys Acta 1775(1):138-162.
36. Wilson VL, Jones PA. 1983. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell 32(1):239-246.
37. Zhang N, Lin C, Huang X, Kolbanovskiy A, Hingerty BE, Amin S, et al. 2005. Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement. J Mol Biol 346(4):951-965.